John Libbey Eurotext

Innovations & Thérapeutiques en Oncologie

Innovations & Thérapeutiques en Oncologie

Volume 7, issue 1, January-February 2021

MENU

Volume 7, issue 1, January-February 2021

Éditorial/Editorial

En accès libre ITO starts a new chapter with a bigger, rejuvenated team! (p.3)
Yacine Merrouche
Free Access

Humeur/Opinion Column

Article Research project. Conception and production of genetically modified coronavirus aimed at individual lethal targeting (p.4-6)
Jacques Robert, Jacques Bonnet

Sélection et décryptage/Comments and Analysis

Article Comments and analysis (p.7-23)
Patricia de Cremoux, Alexandre Bobard, Jacques Robert

Innovations acquises/Established Innovations

Article Habits and therapeutic perceptions around HR+/ HER2 metastatic breast cancer in France, based on results from a national survey (p.24-36)
Julien Péron, Thibaut Reverdy, Sylvie Giacchetti, Ophélie Cassuto, Tullia Devergé, Charlotte Bouyssou, Jean-Marc Ferrero, Elisabeth Luporsi, Florence Lerebours

Innovations en cours/Ongoing Innovations

Article Use of melatonin in cancerology: the paradox (p.37-44)
Matthieu Delaye, Timothée Lacombe, Christine Mateus, Sarah Dauchy

Innovations futures/Future Innovations

Article DNA as a digital database. Something that affects us all! (p.45-50)
Jacques Bonnet, Marthe Colotte, Delphine Coudy, Aurélie Luis, David Georges de Souza, Sophie Tuffet

Les biotechs au coeur de l’innovation/Biotechnology and Innovation

Article A best in class TLR3 agonist soon to be clinically available. TL-532 as new therapeutic approach in immuno-oncology (p.51-6)
Philippe Guillot-Chene

Analyse d’ouvrage/Book Review

Article Nouvelles approches en pharmacologie oncologique (p.57)
Jean-Louis Cazin

Hommage/In Memoriam

En accès libre Le président et la déléguée générale d’Unicancer rendent hommage à Christian Cailliot, ancien directeur de la recherche de la fédération (p.58-9)
Unicancer
Free Access